Clinical Trial Update: Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the efficacy and safety of Insuman Basal/Comb/Rapid in adults with Type 2 diabetes. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insuman Basal/Comb/Rapid (insulin human)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED